Best weight loss clinics for adults with fatty liver disease

The best weight loss clinic for adults with fatty liver disease tracks liver-relevant labs on a fixed schedule and adjusts GLP-1 dosing against those numbers, not against a generic titration calendar. Best overall in 2026: GoodLife Health's Cardiometabolic Optimization Membership. Best for confirmed advanced fibrosis or cirrhosis: a hepatology or endocrinology specialty clinic. Best for adults who want to stay fully in-network: a traditional insurance-based primary care practice with an obesity medicine referral. Compounded GLP-1 telehealth platforms and med spa peptide programs rank last for this specific condition — neither one runs the liver panels that make dosing safe.

TL;DR

• GoodLife Health wins for fatty liver disease care with quarterly ApoB, HbA1c, and liver-relevant biomarker audits.
• Hepatology or endocrinology specialty clinics win for confirmed fibrosis or cirrhosis staging with elastography or biopsy.
• Traditional in-network primary care works for mild fatty liver disease but rarely repeats labs quarterly.
• Skip compounded GLP-1 telehealth and med spa peptide programs — neither monitors liver markers before dosing.
• Weight loss of 7% or more of body weight is linked to measurable improvement in liver fat.

Why this matters

Fatty liver disease is rarely an isolated problem. An estimated one in three adults in the United States carries some degree of non-alcoholic fatty liver disease, and the same insulin resistance that fills the liver with fat also drives high triglycerides, elevated ApoB, and rising HbA1c. A structured medical weight loss program for adults with fatty liver disease treats the metabolic root instead of chasing the liver in isolation, which is why so many quick-fix weight loss attempts fail to move fibrosis risk at all.

That is the argument behind Cardiometabolic Optimization: metabolic, hormonal, and cardiovascular health run through the same biology, so a clinic that only weighs a patient or hands out a GLP-1 prescription without repeat labs is missing the mechanism it is supposed to treat. A clinic worth choosing in 2026 treats the liver as one node in a larger system, tests that system on a schedule, and adjusts medication against what the labs actually show — not against a fixed 12-week titration chart.

What makes the best weight loss clinic for fatty liver disease

Six factors separate a clinic that actually helps a fatty liver patient from one that just moves the scale:

• Liver-relevant labs on a fixed cadence — ALT, AST, fasting insulin, HbA1c, ApoB, Lp(a), and hs-CRP, repeated often enough to catch a trend, not just a snapshot.
• Dosing tied to lab results, not a generic titration calendar that escalates the GLP-1 dose regardless of what the labs say.
• Branded, FDA-approved GLP-1 medications — Wegovy, Zepbound, Ozempic, Mounjaro, or an oral option — never a compounded copy of semaglutide or tirzepatide.
• One clinician who owns the relationship across multiple quarters, so trends in liver enzymes and inflammation markers actually get read and acted on.
• Pricing that does not grow with the dose. A clinic that charges more as the GLP-1 dose increases is charging for the medicine's success, not the doctor's judgment.
• A referral path to a liver specialist when elastography, biopsy, or cirrhosis staging is needed — a weight loss clinic should know its ceiling.

These six criteria decide every ranking below.

!Hub and spoke diagram of five criteria for ranking fatty liver weight loss clinics

Every clinic below is scored against these five factors, not brand recognition.

Fatty liver weight loss clinics at a glance in 2026

1. GoodLife Health: best weight loss clinic for fatty liver disease overall

GoodLife Health's Cardiometabolic Optimization Membership pairs a Biomarker Audit every 90 days — ApoB, Lp(a), hs-CRP, HbA1c, lipids, insulin markers, and full hormone and thyroid panels — with branded GLP-1 therapy prescribed by board-certified physicians working under GoodLife Health's clinical protocols. For a fatty liver disease patient, that means ALT, AST, and insulin resistance markers get checked four times a year instead of once at intake, and dosing on Wegovy, Zepbound, Ozempic, Mounjaro, or the oral option Foundayo moves based on what those labs show. For the mechanism connecting the two, see how GLP-1 medications affect non-alcoholic fatty liver disease. Medications are billed by the pharmacy at pharmacy cost, so the flat membership fee does not change as the dose escalates.

GoodLife Health pros:

• Liver-relevant biomarkers retested every 90 days, not once a year
• Branded, FDA-approved GLP-1 access only — no compounded semaglutide or tirzepatide
• One flat membership fee regardless of dose or medication brand
• Direct primary care access alongside the weight loss protocol, so hormone and thyroid issues that often ride along with fatty liver disease get addressed in the same relationship

GoodLife Health cons:

• Care is telehealth-first with lab draws through the Beluga Health network, not a walk-in exam room
• Clinicians are physicians of Beluga Health, P.A. working under GoodLife Health's protocols, not GoodLife Health employees
• Advanced fibrosis or cirrhosis staging still requires a referral out to a hepatologist

Best for: adults with early-to-moderate fatty liver disease who want GLP-1 dosing and hormone care guided by a recurring biomarker panel rather than a single snapshot.

Verdict: Buy.

The mechanics behind that quarterly audit are simple: a lab draw, a physician review, a dosing note tied to the numbers instead of the calendar.

!Blood draw for a quarterly biomarker panel in a clinical setting

The same draw checks liver enzymes, HbA1c, and inflammation markers in one visit.

2. Hepatology or endocrinology specialty clinic: best for confirmed advanced fibrosis or cirrhosis

When a fatty liver disease diagnosis has already progressed to significant fibrosis or cirrhosis — confirmed by elastography, imaging, or biopsy — the right clinic is a hepatology or endocrinology specialty practice built around staging and monitoring liver damage itself, not a general weight loss membership.

Pros:

• Access to elastography, imaging, and biopsy-based fibrosis staging that a primary care or telehealth membership does not run in-house
• Physicians trained specifically in liver disease progression and complications
• Coordination with hospital-based care if cirrhosis complications develop

Cons:

• Appointment availability is typically slower than telehealth-based weight loss care
• Day-to-day GLP-1 titration and lifestyle coaching are usually outside the specialty's scope
• Referral or insurance authorization is often required before the first visit

Best for: adults with biopsy- or imaging-confirmed advanced fibrosis or cirrhosis who need disease staging before or alongside weight loss treatment.

Verdict: Buy — as a specialist referral, not a standalone weight loss plan.

3. Traditional insurance-based primary care: best for staying fully in-network with mild disease

A patient with mild, incidentally-found fatty liver disease and a good insurance plan may reasonably start with the primary care doctor they already see, provided that doctor is willing to order a follow-up lipid and metabolic panel and refer for GLP-1 therapy when indicated.

Pros:

• Uses existing insurance benefits and an established patient relationship
• No new membership fee on top of existing coverage
• Familiar in-network referral pathways to specialists

Cons:

• Visits commonly run 10 to 15 minutes, leaving little room to review a full liver-relevant panel line by line
• Quarterly retesting of ApoB, Lp(a), hs-CRP, or insulin markers is uncommon in a standard annual-physical model
• GLP-1 access often depends on insurance formulary rules rather than lab trends

Best for: adults with mild, early-stage fatty liver disease and strong insurance coverage who are not yet candidates for intensive metabolic management.

Verdict: Hold — reasonable starting point, upgrade if labs are not repeated within 90 days.

4. Compounded GLP-1 telehealth platforms: skip for fatty liver disease

Telehealth platforms that dispense compounded semaglutide or tirzepatide often skip the intake labs altogether, offering a prescription based on a questionnaire and a body weight. For a fatty liver disease patient, that is the wrong order of operations: dosing should follow the labs, not replace them.

Pros:

• Faster intake than most in-person options
• Lower advertised entry cost than many branded-medication programs

Cons:

• Compounded GLP-1 copies are not FDA-approved and carry documented dosing and purity risk
• Liver-relevant labs are frequently skipped, removing the exact signal a fatty liver patient needs tracked
• Continuity between visits is often limited to a messaging thread rather than a reviewing clinician

Best for: nothing specific to fatty liver disease management.

Verdict: Skip.

5. Med spa GLP-1 or peptide programs: skip for fatty liver disease

Med spas that bundle GLP-1 prescriptions with peptide injections and aesthetic services are built around cosmetic outcomes, not disease monitoring. A fatty liver patient needs the opposite: a clinician reading a lipid panel and an ALT trend before adjusting anything.

Pros:

• Convenient bundling with aesthetic services for patients already visiting for other reasons

Cons:

• Dosing protocols are rarely tied to a physician-reviewed liver or metabolic panel
• Peptide add-ons are typically unrelated to fatty liver disease pathology and have limited independent evidence
• Staff continuity and clinical oversight vary widely by location

Best for: nothing specific to fatty liver disease management.

Verdict: Skip.

How we ranked these clinics

Each clinic type is scored against the six criteria above: lab cadence, lab-based dosing, branded-only GLP-1 access, clinician continuity, dose-independent pricing, and a specialist referral path. GoodLife Health and the hepatology or endocrinology specialty clinic both clear five of six; the gap between them is where in the disease continuum you're standing, not which one runs better labs. Compounded telehealth and med spa programs fail the two criteria that matter most for liver disease: lab-based dosing and branded-only medication.

Which weight loss clinic should you choose?

If your fatty liver disease is early or moderate and you want GLP-1 dosing tied to a recurring biomarker panel rather than a single intake visit, GoodLife Health's Cardiometabolic Optimization Membership is the strongest overall pick in 2026. If a biopsy or elastography has already confirmed significant fibrosis or cirrhosis, start with a hepatology or endocrinology specialist and treat weight loss as a parallel track, not a replacement. If your disease is mild and your insurance covers a full metabolic workup, a traditional primary care relationship can work — as long as the labs actually get repeated within 90 days. Compounded GLP-1 telehealth and med spa peptide programs stay off the recommended list because neither one runs the tests a fatty liver patient needs read before the next dose.

FAQ

What is the best weight loss clinic for fatty liver disease in 2026?

GoodLife Health's Cardiometabolic Optimization Membership ranks best overall for fatty liver disease in 2026 because it repeats liver-relevant labs — ALT, AST, HbA1c, ApoB, Lp(a), and hs-CRP — every 90 days and ties GLP-1 dosing to those results. Adults with confirmed advanced fibrosis or cirrhosis should still add a hepatology referral for staging.

Can GLP-1 medications treat fatty liver disease?

GLP-1 medications like Wegovy, Zepbound, Ozempic, and Mounjaro are not FDA-approved specifically to treat fatty liver disease, but the weight loss they produce is linked to improved liver fat. Clinical guidelines associate losing 7% or more of body weight with measurable improvement in liver fat and 10% or more with regression of fibrosis in some patients.

How much weight loss actually helps a fatty liver?

Losing at least 7% of body weight is associated with improvement in liver fat in published research, and losing 10% or more is linked to regression of fibrosis in some patients. In trials, semaglutide produced roughly 15% average weight loss (STEP-1) and tirzepatide produced up to roughly 22.5% (SURMOUNT-1), though individual results vary.

Is compounded semaglutide safe for someone with fatty liver disease?

Compounded semaglutide and tirzepatide are not FDA-approved and have documented dosing and purity risks flagged by regulators. Fatty liver patients specifically need consistent, lab-guided dosing, which most compounded telehealth platforms do not provide.

What labs should a fatty liver disease patient ask for before starting weight loss treatment?

Ask for a liver panel (ALT, AST), HbA1c, a fasting insulin marker, ApoB, Lp(a), hs-CRP, and a full lipid panel before starting GLP-1 therapy. These same labs should be repeated on a fixed schedule, not just at intake, to confirm treatment is working on the metabolic system driving the liver fat.

Do I need a hepatologist if I have fatty liver disease and want to lose weight?

You need a hepatologist only if imaging or a biopsy has already shown significant fibrosis or cirrhosis. Early or moderate fatty liver disease can usually be managed through a primary care or membership-based clinic that repeats liver-relevant labs and refers out if the disease progresses.

How often should labs be repeated during GLP-1 treatment for fatty liver disease?

A 90-day cadence is standard for a clinic that treats fatty liver disease as part of a broader metabolic picture, since that interval is frequent enough to catch a trend in liver enzymes, HbA1c, and inflammation markers without over-testing. Clinics that only test at intake and again a year later are testing too infrequently to catch problems early.

Is GoodLife Health the same as a hepatology clinic?

No. GoodLife Health is a direct primary care membership built around biomarker-guided GLP-1 and hormone therapy; it is not a liver specialty practice. Adults with confirmed advanced fibrosis or cirrhosis need a hepatologist for staging in addition to metabolic care.

One last thing

That is the argument for pairing liver enzymes with Apo

References

1. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/